{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:12:23Z","timestamp":1790439143403,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"7","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.humimm.2013.03.004","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T18:33:44Z","timestamp":1366137224000},"page":"849-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antibodies to active zone protein ERC1 in Lambert\u2013Eaton myasthenic syndrome"],"prefix":"10.1016","volume":"74","author":[{"given":"Maartje G.","family":"Huijbers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander F.","family":"Lipka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Potman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Hensbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Titulaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik H.","family":"Niks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silv\u00e8re M.","family":"van der Maarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinse","family":"Klooster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.humimm.2013.03.004_b0005","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","article-title":"Verschuuren JJ Lambert\u2013Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies","volume":"10","author":"Titulaer","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.humimm.2013.03.004_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","article-title":"Incidence of serum anti-P\/Q-type and anti-N-type calcium channel autoantibodies in the Lambert\u2013Eaton myasthenic syndrome","volume":"147","author":"Motomura","year":"1997","journal-title":"J Neurol Sci"},{"issue":"7","key":"10.1016\/j.humimm.2013.03.004_b0015","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.2010.32.0440","article-title":"Clinical Dutch-English Lambert\u2013Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS","volume":"29","author":"Titulaer","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.humimm.2013.03.004_b0020","doi-asserted-by":"crossref","first-page":"e13854","DOI":"10.1371\/journal.pone.0013854","article-title":"Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and intergrity","volume":"5","author":"de Morr\u00e9e","year":"2010","journal-title":"Plos One"},{"issue":"26","key":"10.1016\/j.humimm.2013.03.004_b0025","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1200\/JCO.2008.20.6169","article-title":"Sox antibodies in small-cell lung cancer and Lambert\u2013Eaton myasthenic syndrome: frequency and relation with survival","volume":"27","author":"Titulaer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humimm.2013.03.004_b0030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"8","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.humimm.2013.03.004_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/jb\/mvq065","article-title":"CAST and ELKS proteins: structural and functional determinants of the presynaptic active zone","volume":"148","author":"Hida","year":"2010","journal-title":"J Biochem"},{"issue":"5679","key":"10.1016\/j.humimm.2013.03.004_b0040","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1126\/science.1098387","article-title":"Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit","volume":"304","author":"Ducut Sigala","year":"2004","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.humimm.2013.03.004_b0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/WNR.0b013e32834e7deb","article-title":"ELKS1 and Ca2+ channel subunit 4 interact and colocalize at cerebellar synapses","volume":"23","author":"Billings","year":"2012","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.humimm.2013.03.004_b0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.410170610","article-title":"Action of Lambert\u2013Eaton myasthenic syndrome IgG at mouse motor nerve terminals","volume":"17","author":"Prior","year":"1985","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.humimm.2013.03.004_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-5728(00)00431-8","article-title":"Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line","volume":"113","author":"Benatar","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.humimm.2013.03.004_b0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2008.04.040","article-title":"Lambert\u2013Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis","volume":"201\u2013202","author":"Takamori","year":"2008","journal-title":"J Neuroimmunol"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T01:21:52Z","timestamp":1539739312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885913000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0198885913000852"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2013.03.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to active zone protein ERC1 in Lambert\u2013Eaton myasthenic syndrome","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2013.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}